In conclusion, the prognosis of pediatric BCP-ALL patients with TCF3-PBX1 fusion treated according to the JACLS ALL02 and CCLSG ALL2004 protocol was similar to that reported in studies performed in Western countries. Here, PBX1 is linked to acute lymphoblastic leukemia.